Overview

Effectiveness of Drug Eluting TACE in Primary HCC

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
the aim of this work to compare effectiveness of drug-eluting bead trans-arterial chemo-embolization and conventional trans-arterial chemo-embolization of hepatic cell carcinoma in the aspect of (Tumor response via m-RECIST criteria), (liver injury via Liver function tests and tumor markers) and (survival outcome) of patients treated in Assiut university .
Phase:
Early Phase 1
Details
Lead Sponsor:
Assiut University
Treatments:
Doxorubicin
Ethiodized Oil
Liposomal doxorubicin